Brian Hodous, Ph.D., promoted to chief scientific officer-- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical scienc ...

Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

A research team led by Professor Takuya Yamamoto (Department of Life Science Frontiers) and Professor Yasuhiro Yamada at the University of Tokyo has developed a novel in vivo system that reveals how ...

Cancer therapies called checkpoint inhibitor drugs, which ratchet up the immune system, work better when this bacterium is ...